To predict the influence of MCI-2016 on cerebral energy metabolism, the activity of MCI-2016 on a) uptake of 2-deoxy-D-[
14C]glucose ([
14C]-DG) into the brain under normal or hypoxic conditions, b) formation of
14CO
2 from
14C-glucose in the brain, and c) local cerebral glucose utilization (LCGU) were examined. Cerebral uptake of [
14C]-DG in mice were significantly enhanced by 6 day repeated administration of MCI-2016 (25 mg/kg, i.p.) and Ca-hopantenate (100 mg/kg, i.p.). The two drugs showed a slight enhancing effect on [
14C]-DG uptake after single administration. As an index of cerebral glucose metabolism,
14CO
2 formation from
14C-glucose was also stimulated by 6 day repeated administration of MCI-2016 (100 mg/kg, p.o., mice and rats) and Ca-hopantenate (250 mg/kg, i.p., rats). MCI-2016 moderately attenuated the decreased [
14C]-DG uptake under the hypoxic condition in rats after 6 day repeated administration (100 mg/kg, p.o.). In addition, local cerebral glucose utilization (LCGU) in rats was also significantly potentiated by MCI-2016 (100 mg/kg, p.o., 6 days) in the areas of the visual cortex, thalamus ventral nucleus and uvula. From these results, MCI-2016 may be suggested to have a moderate activating effect on cerebral energy metabolism.
View full abstract